Status:
UNKNOWN
Determinants on Rocuronium Dose for Deep Block in Bariatric Surgery
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Bariatric Surgery
Eligibility:
All Genders
20-80 years
Brief Summary
Find out the deciding factor(total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index, skeletal muscle mass, body fat) of neuromuscular blocker dose for deep neuromu...
Detailed Description
Before the surgery, total body weight, corrected body weight, ideal body weight, fat-free mass, body mass index were measured by height and weight and skeletal muscle mass and body fat were measured b...
Eligibility Criteria
Inclusion
- Patients aged 20-80 and American Society of Anesthesiology Physical Grade (ASA) I-II, who undergo bariatric surgery
Exclusion
- kidney disease (GFR\<60)
- allergy to study drugs
- decline participation
- side effect of propofol and remifentanil
- when anesthesia does not maintain the level of alertness (BIS) below 60 even when the anesthetic dose is increased, or when hemodynamic instability such as bradycardia and hypotension appears
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04709406
Start Date
January 1 2021
End Date
October 1 2021
Last Update
January 14 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.